Tag Archives: Juno Therapeutics

Leerink Swann Downgrades Juno Therapeutics to Hold

Leerink Swann analyst Michael Schmidt downgraded Juno Therapeutics (NASDAQ: JUNO) to Hold today and set a price target of $87. The company’s shares closed yesterday at $86, close to its 52-week high of $86.28. According to TipRanks.com, Schmidt is a

J.P. Morgan Gives a Hold Rating to Juno Therapeutics

In a report issued on January 9, Cory Kasimov from J.P. Morgan assigned a Hold rating to Juno Therapeutics (NASDAQ: JUNO). The company’s shares closed yesterday at $48.94. According to TipRanks.com, Kasimov is a 4-star analyst with an average return

Maxim Group Releases a Buy Rating on Juno Therapeutics

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Juno Therapeutics (NASDAQ: JUNO), with a price target of $56. The company’s shares closed yesterday at $45.75. McCarthy observed: “The American Society of Hematology (ASH)

Raymond James Keeps a Buy Rating on Juno Therapeutics

Raymond James analyst Reni Benjamin maintained a Buy rating on Juno Therapeutics (NASDAQ: JUNO) yesterday. The company’s shares closed yesterday at $50.24. Benjamin observed: “Recommendation: We are maintaining our Outperform rating for JUNO. At the 2017 American Society of Hematology

Analysts Have Conflicting Sentiments on These Healthcare Companies: Juno Therapeutics (NASDAQ: JUNO), Amag Pharmaceuticals (NASDAQ: AMAG) and Aerie Pharma (NASDAQ: AERI)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Juno Therapeutics (NASDAQ: JUNO), Amag Pharmaceuticals (NASDAQ: AMAG) and Aerie Pharma (NASDAQ: AERI). Juno Therapeutics (NASDAQ: JUNO) In a report released yesterday, Chris Shibutani from

Cowen & Co. Believes Juno Therapeutics (NASDAQ: JUNO) Still Has Room to Grow

In a report released yesterday, Chris Shibutani from Cowen & Co. reiterated a Buy rating on Juno Therapeutics (NASDAQ: JUNO), with a price target of $49. The company’s shares closed yesterday at $43.53, close to its 52-week high of $47.03.